Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Yu Yang

1PUBLICATIONS

4CO-AUTHORS

Human impacts of climate change and human adaptation

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|May 23, 2023

SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.

Michael C Warren, Stephan Matissek, Matthew Rausch

Pageof 1

Frequent Collaborators

1 joint publications

Matthew Rausch

1 joint publications

Marisella Panduro

1 joint publications

Célia Jacoberger Foissac

1 joint publications

John Stagg

Frequent Collaborators

1 joint publications

Matthew Rausch

1 joint publications

Marisella Panduro

1 joint publications

Célia Jacoberger Foissac

1 joint publications

John Stagg

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

See more related videos

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

See more related videos